The regulation of HDAC6 by cylindromatosis (CYLD), which is a tumour suppressor protein mutated in benign skin tumours, shows that the regulation of HDAC6 activity by protein–protein interactions occurs in cancer. This evidence concerns the gene HDAC6 and benign neoplasm of skin.